|
Market Closed -
Bombay S.E.
06:02:25 2026-09-16 EDT
|
5-day change | 1st Jan Change | ||
| 22,653.10 INR | +0.58% |
|
-5.51% | +49.13% |
| 09-07 | Indian shares on track for muted open as oil climbs on rising Mideast risks | RE |
| 08-05 | Neuland Laboratories Limited, Q1 2027 Earnings Call, Aug 05, 2026 |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 3.01B | |||||
| 1,013B | |||||
| 644B | - | ||||
| 465B | |||||
| 352B | |||||
| 264B |
Select your edition
All financial news and data tailored to specific country editions
